| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EURJHF/HFR063 |
| P698 | PubMed publication ID | 21791542 |
| P50 | author | Kenneth M. McDonald | Q64030914 |
| Mark T Ledwidge | Q64030916 | ||
| P2093 | author name string | Margaret Bermingham | |
| Ian Dawkins | |||
| Saki Miwa | |||
| Eleanor O'Callaghan | |||
| Shazzarina Samsudin | |||
| P2860 | cites work | Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology | Q30483582 |
| beta-adrenergic receptor blockade in chronic heart failure | Q33831388 | ||
| Adverse effects of beta-agonists | Q35016429 | ||
| Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest | Q35040922 | ||
| The diagnosis and management of patients admitted to hospital with acute breathlessness | Q39068543 | ||
| Adverse consequences of high sympathetic nervous activity in the failing human heart | Q41673274 | ||
| Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study | Q42255682 | ||
| Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial | Q43088587 | ||
| Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme | Q43113040 | ||
| Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease | Q43598623 | ||
| Chronically inhaled salmeterol improves pulmonary function in heart failure. | Q44033594 | ||
| High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale | Q44242029 | ||
| Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. | Q45933194 | ||
| Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. | Q53643383 | ||
| Hemodynamic effects of inhaled terbutaline in congestive heart failure patients without lung disease: Beneficial cardiotonic and vasodilator beta-agonist properties evaluated by ventricular catheterization and radionuclide angiography | Q54535860 | ||
| P433 | issue | 8 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 885-891 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Are beta2-agonists responsible for increased mortality in heart failure? | |
| P478 | volume | 13 |
| Q38796735 | An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly |
| Q38225445 | BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure |
| Q30251770 | Challenges in the pharmacological treatment of geriatric asthma. |
| Q88711804 | Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease |
| Q38944856 | Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care |
| Q88141790 | Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study |
| Q38749254 | Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease? |
| Q38119867 | Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services |
| Q55708953 | Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol. |
| Q37198408 | Impact of beta2-agonists, beta-blockers, and their combination on cardiac function in elderly male patients with chronic obstructive pulmonary disease |
| Q83831164 | Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure |
| Q38871993 | Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases |
| Q38537053 | Management of Noncardiac Comorbidities in Chronic Heart Failure |
| Q97538245 | Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients |
| Q43849764 | Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor. |
| Q47792766 | Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease. |
| Q28066822 | Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics |
| Q38152743 | β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives. |
Search more.